Facebook Twitter LinkedIn
CIS

CIS

The science and practice of human immunology

The science and practice of human immunology
| MENU |

Continuing Medical Education

2014 Annual Meeting

Purpose
The purpose is to provide an intellectual forum for all clinicians and researchers from around the world to discuss diagnosis, pathogenesis, and management of the regulation and dysregulation of immunity.

Target Audience
The target audience is physicians and researchers working in various clinical immunology specialties including, but not limited to, allergy, autoimmunity, dermatology, gastroenterology, hematology, infectious disease, primary immunodeficiency, rheumatology, and transplantation.

Learning Objectives
At the completion of the activity participants should be able to:

  • Recognize the value of new research techniques;
  • Describe new research findings in immunology;
  • Explain the diagnosis and management of diseases and disorders across various subspecialties of medicine.

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The Clinical Immunology Society designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

School on Diagnostic Assessment of Immune Phenotyping and Function in PIDs

Purpose
The purpose is to provide an intellectual forum for all clinicians and researchers from around the world to discuss diagnosis, pathogenesis, and management of the regulation and dysregulation of immunity.

Target Audience
The target audience are clinical allergists/immunologists, clinical immunologists, rheumatologists, infectious disease and hematologists who specifically focus in the care and treatment of patients with primary immunodeficiencies (PIDs).  Additionally, the target audience includes clinical laboratory immunologists, other PhD level immunologists and scientists along with fellows in training in the above-mentioned clinical disciplines.

Learning Objectives
At the completion of the activity participants should be able to:

  • Describe and interpret new defects in innate immunity and relevant diagnostic tools for the evaluation of patients
  • Interpretation and application of molecular, specifically genetic, techniques in the diagnosis of primary immunodeficiencies
  • State, interpret and employ state-of-the-art tools for newborn screening for selected primary immunodeficiencies
  • Define, interpret and apply information on use of flow cytometric techniques for diagnosis and monitoring of patients with PIDs
  • Recall and explain the clinical and immunological phenotype of radiation sensitivity and DNA repair defects along with application of new methods for diagnosis

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The Clinical Immunology Society designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.